Edmond De Rothschild Holding S.A. Amgen Inc Transaction History

Edmond De Rothschild Holding S.A.

$6.04 Billion
Q3 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Amgen Inc stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 2,228 shares of AMGN stock, worth $592,536. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,228

Previous 1,919 16.1%

Holding current value

$592,536

Previous $599,000 19.7%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $95,598 - $104,250	309 Added 16.1%	2,228 $717,000
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $81,715 - $99,305	-311 Reduced 13.95%	1,919 $599,000
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $232,841 - $281,068	866 Added 63.49%	2,230 $634,000
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $2.72 Million - $3.07 Million	-10,631 Reduced 88.63%	1,364 $392,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $13.5 Million - $16.8 Million	-61,754 Reduced 83.74%	11,995 $3.22 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $756,801 - $894,902	-3,532 Reduced 4.57%	73,749 $16.4 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $8.07 Million - $9.84 Million	-35,756 Reduced 31.63%	77,281 $18.7 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $2.14 Million - $2.72 Million	-9,338 Reduced 7.63%	113,037 $29.7 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $739,820 - $834,382	-3,296 Reduced 2.62%	122,375 $27.6 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $11 Million - $12.3 Million	-47,854 Reduced 27.58%	125,671 $30.6 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $1.35 Million - $1.49 Million	6,155 Added 3.68%	173,525 $42 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $2 Million - $2.29 Million	-10,075 Reduced 5.68%	167,370 $37.7 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $329,018 - $385,485	-1,550 Reduced 0.87%	177,445 $37.7 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $12.2 Million - $13.6 Million	52,328 Added 41.31%	178,995 $43.6 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $12.4 Million - $14.5 Million	56,058 Added 79.39%	126,667 $31.5 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.69 Million - $2.01 Million	7,809 Added 12.43%	70,609 $16.2 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $7.64 Million - $8.5 Million	-32,570 Reduced 34.15%	62,800 $16 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $6.53 Million - $8.01 Million	33,013 Added 52.94%	95,370 $22.5 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $384,344 - $509,745	-2,109 Reduced 3.27%	62,357 $12.6 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $788,248 - $1.01 Million	-4,166 Reduced 6.07%	64,466 $15.5 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $3.86 Million - $4.62 Million	22,153 Added 47.66%	68,632 $13.3 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $5 Million - $5.86 Million	30,010 Added 182.22%	46,479 $8.57 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $180 - $203	1 Added 0.01%	16,469 $3.13 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $35,680 - $41,650	-200 Reduced 1.2%	16,468 $3.21 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $25,199 - $28,409	-136 Reduced 0.81%	16,668 $3.46 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $66,420 - $74,604	400 Added 2.44%	16,804 $3.1 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $1.34 Million - $1.57 Million	-7,920 Reduced 32.56%	16,404 $2.8 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $439,022 - $490,522	-2,601 Reduced 9.66%	24,324 $4.23 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $4.5 Million - $5.14 Million	26,925	26,925 $5.02 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Account

Edmond De Rothschild Holding S.A. Amgen Inc Transaction History